Table 3. Drug resistance profiles for second-line drugs MDR-TB cases according to new cases and previously treated cases (n = 14), 2020.
Drug resistance pattern | Isolates from new cases, n (%) | Isolates from previously treated cases, n (%) | Total n (%) |
---|---|---|---|
Total Isolate | 11 | 3 | 14 |
Amikacin | - | - | - |
Capromycin | 1(9.1) | - | 1 (7.1) |
Ethionamide | 1(9.1) | - | 1(7.1) |
Kanamycin | - | - | - |
Ofloxacin | 1(9.1) | 1(33.3) | 2 (14.3) |
Moxifloxacin | 1(9.1) | 1(33.3) | 2 (14.3) |
Pre-XDR | 2(18.2) | 1(33.3) | 3 (21.4) |
XDR-Extensively Drug-Resistant.